Predictive Value of Bio-impedance Vector Analysis on Long-term Outcome in ICU Patients

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04449796

Enrollment

1025

Registered

2020-06-29

Start date

2018-06-01

Completion date

2020-06-01

Last updated

2020-07-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Long-term Outcome, Survival

Brief summary

Detailed description

Phase angle, derived from bioimpedance analysis (BIA), reflects tissue quality and quantity in which cell mass, membrane integrity and hydration state are represented. Phase angle, as a measure of body composition, changes with the physical condition of patients and is associated with survival in several disease states and during ICU admission. Aim of the study is to explore the predictive value of the phase angle for long term ICU survival. A single-centre prospective observational cohort will be performed with consecutive patients, elective and non elective, admitted to the ICU between 1st June 2018 and 1st June 2019. Demographic data, APACHE III, comorbidity and phase angle are collected and the ICU- , hospital- and 6 months survival will be registered.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* all patients admitted to the ICU, elective and acute.

Exclusion criteria

* age below 18 * Length of stay at ICU \< 6 hours * All invalid bio-impedence analysis (BIA) measurements

Design outcomes

Primary

Measure	Time frame	Description
3 months survival	3 months	100% minus all-cause mortality at three month post ICU
6 months survival	6 months	100% minus all-cause mortality at six month post ICU
12 months survival	12 months	100% minus all-cause mortalityat twelve month post ICU

Countries

Netherlands

Outcome results